Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RAMUCIRUMAB vs RANOLAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RAMUCIRUMAB vs RANOLAZINE: Safety Overview

Metric RAMUCIRUMAB RANOLAZINE
Total FAERS Reports 5,357 9,522
Deaths Reported 1,444 1,048
Death Rate 27.0% 11.0%
Hospitalizations 2,066 3,367
Average Patient Age 63.9 yrs 70.4 yrs
% Female Patients 33.0% 42.0%
FDA Approval Date N/A Apr 15, 2025
Manufacturer Eli Lilly and Company AvKARE
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued